Seeking to limit its exposure, ChemChina began reaching out last year to state funds, including China Reform Holdings, and the country’s $40 billion Silk Road Fund, for equity investment, people familiar with the matter said previously. It also sought out private-equity firms and sovereign funds, these people said.